Evidence map›Paper›PMID 31042030›Full record

ArticleJournal of the American Chemical Society2019

Inhibition of HIV Maturation via Selective Unfolding and Cross-Linking of Gag Polyprotein by a Mercaptobenzamide Acetylator.

Lisa M Miller Jenkins, Elliott L Paine, Lalit Deshmukh, Herman Nikolayevskiy, Gaelyn C Lyons, Michael T Scerba, Kara George Rosenker, Hans F Luecke, John M Louis, Elena Chertova and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Lisa M Miller JenkinsLaboratory of Cell Biology , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States.
Elliott L PaineLaboratory of Cell Biology , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States.
Lalit Deshmukh
Herman Nikolayevskiy
Gaelyn C LyonsLaboratory of Cell Biology , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States.
Michael T Scerba
Kara George Rosenker
Hans F Luecke
John M Louis
Elena ChertovaAIDS and Cancer Virus Program, Leidos Biomedical Research Inc. , Frederick National Laboratory for Cancer Research , Frederick , Maryland 21701 , United States.
Robert J GorelickAIDS and Cancer Virus Program, Leidos Biomedical Research Inc. , Frederick National Laboratory for Cancer Research , Frederick , Maryland 21701 , United States.
David E OttAIDS and Cancer Virus Program, Leidos Biomedical Research Inc. , Frederick National Laboratory for Cancer Research , Frederick , Maryland 21701 , United States.
National Institute of Diabetes and Digestive and Kidney Diseases · USLeidos (United States) · USNational Institutes of Health · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Structure and Dynamics Of Macromolecules In Solution By NMRZIADK029023 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CLORE, GIDEON · 2009 to 2025
$41.5M
CPTR - Mass Spectrometry UnitZICBC011430 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JENKINS, LISA · 2012 to 2025
$9.4M
Small Molecular Inactivators of HIVZIADK075135 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI APPELLA, DANIEL H · 2016 to 2025
$7.2M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIC BC011430NCATS NIH HHS UL1 TR001442NCI NIH HHS HHSN261200800001ENIAID NIH HHS P30 AI036214
6 · The paper itself

Abstract

For HIV to become infectious, any new virion produced from an infected cell must undergo a maturation process that involves the assembly of viral polyproteins Gag and Gag-Pol at the membrane surface. The self-assembly of these viral proteins drives formation of a new viral particle as well as the activation of HIV protease, which is needed to cleave the polyproteins so that the final core structure of the virus will properly form. Molecules that interfere with HIV maturation will prevent any new virions from infecting additional cells. In this manuscript, we characterize the unique mechanism by which a mercaptobenzamide thioester small molecule (SAMT-247) interferes with HIV maturation via a series of selective acetylations at highly conserved cysteine and lysine residues in Gag and Gag-Pol polyproteins. The results provide the first insights into how acetylation can be utilized to perturb the process of HIV maturation and reveal a new strategy to limit the infectivity of HIV.

Indexed as

AcetylationAmino Acid SequenceAnti-HIV AgentsBenzamidesCell LineCysteineFusion Proteins, gag-polgag Gene Products, Human Immunodeficiency VirusHIVHumansLysineProtein UnfoldingVirus AssemblyAnti-HIV AgentsBenzamidesCysteineFusion Proteins, gag-polgag Gene Products, Human Immunodeficiency VirusLysine

Identifiers

PMID31042030
PMCPMC8496520
OpenAlexW2943402039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.